Vanguard Group Inc Liquidia Corp Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Vanguard Group Inc holds 2,887,274 shares of LQDA stock, worth $34.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,887,274

Previous 2,843,922 1.52%

Holding current value

$34.2 Million

Previous $34.2 Million 24.48%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$11.35 - $16.73 $492,045 - $725,278	43,352 Added 1.52%	2,887,274 $42.6 Million
Q4 2023 Feb 14, 2024	BUY	$5.77 - $12.19 $401,153 - $847,497	69,524 Added 2.51%	2,843,922 $34.2 Million
Q3 2023 Nov 14, 2023	BUY	$6.27 - $8.15 $167,271 - $217,425	26,678 Added 0.97%	2,774,398 $17.6 Million
Q2 2023 Aug 14, 2023	BUY	$6.63 - $9.9 $1.13 Million - $1.69 Million	170,782 Added 6.63%	2,747,720 $21.6 Million
Q1 2023 May 15, 2023	BUY	$5.72 - $7.91 $122,648 - $169,606	21,442 Added 0.84%	2,576,938 $17.8 Million

Q4 2022 Feb 10, 2023	SELL	$4.68 - $6.54 $111,332 - $155,580	-23,789 Reduced 0.92%	2,555,496 $16.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $577,113 - $1.3 Million	154,722 Added 6.38%	2,579,285 $14 Million
Q2 2022 Aug 12, 2022	BUY	$3.37 - $7.55 $2.58 Million - $5.78 Million	765,481 Added 46.14%	2,424,563 $10.6 Million
Q1 2022 May 13, 2022	BUY	$5.14 - $7.38 $242,407 - $348,048	47,161 Added 2.93%	1,659,082 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $73,977 - $141,130	27,298 Added 1.72%	1,611,921 $7.85 Million
Q3 2021 Nov 12, 2021	BUY	$2.28 - $2.95 $176,444 - $228,294	77,388 Added 5.13%	1,584,623 $4.37 Million
Q2 2021 Aug 13, 2021	BUY	$2.51 - $3.11 $3.78 Million - $4.69 Million	1,507,235 New	1,507,235 $4.31 Million

Others Institutions Holding LQDA

# of Institutions

157

Shares Held

35.5M

Call Options Held

1.68M

Put Options Held

1.17M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $761M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Liquidia Corp Transaction History